Table 5.

Adverse events, regardless of study drug relationship, by hepatic function group, preferred term, and maximum grade (Safety set)

Primary system organ class Preferred term, n (%)a	Control (N = 11)	Moderate (N=6)	Severe (N=6)	All Participants (N=23)
Any Grade	1 (9.1)	2 (33.3)	0	3 (13.0)
Grade 1	1 (9.1)	1 (16.7)	0	2 (8.7)
Grade 2	0	1 (16.7)	0	1 (4.3)
Nausea	0	2 (33.3)	0	2 (8.7)
Blood pressure increased	0	1 (16.7)	0	1 (4.3)
Dizziness	1 (9.1)	0	0	1 (4.3)

^aA participant with multiple occurrences of an adverse event under a hepatic function group is counted only once in the adverse event category for that group. A participant with multiple adverse events within a primary system organ class is counted only once in the total row at maximum severity grade.